spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
ad-til
takeda pharma ltda. - acetato de retinol, colecalciferol - polivitaminicos sem minerais
frutosse
laboratÓrio farmacÊutico caresse ltda me - ambroxol, cloridrato de ambroxol - expectorantes balsamicos e mucolitico
mucosolvan
sanofi-aventis farmacÊutica ltda - cloridrato de ambroxol - expectorantes balsamicos e mucolitico
cloridrato de ambroxol
nativita ind. com. ltda. - cloridrato de ambroxol - expectorantes balsamicos e mucolitico
aerodivent
laboratÓrio teuto brasileiro s/a - brometo de ipratrÓpio - broncodilatadores
anador
sanofi-aventis farmacÊutica ltda - dipirona - analgesicos nao narcoticos
atrovex
medquimica industria farmaceutica ltda. - butilbrometo de escopolamina, dipirona monoidratada - antiespasmodicos e anticolinergicos-assoc medicamentosas
bextra im/iv
laboratÓrios pfizer ltda - parecoxibe sÓdico - antinflamatorios
bisolvon
sanofi-aventis farmacÊutica ltda - cloridrato de bromexina - expectorantes